Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 1, 1999, Pages 128-137

  Su, Min Ying ^a   Wang, Zhiheng ^a   Nalcioglu, Orhan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemotherapy; MR contrast agents; Pharmacokinetic analysis; Therapy efficacy; Vascular permeability; Vascular volume

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOMER 17; UNCLASSIFIED DRUG;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR DIAGNOSIS; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CAPILLARY PERMEABILITY; CONTRAST MEDIA; FEMALE; FLAVONOIDS; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MITOMYCIN; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0032950741     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199901)9:1<128::AID-JMRI17>3.0.CO;2-E     Document Type: Article

References (30)

1. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor responses to chemotherapy. Radiology 1992;184: 243-248.
2. Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, Di Paola R. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 1992;27:847-855.
3. Evelhoch J, Cunnings A, Lucas D, et al Early detection of therapeutic response by dynamic contrast-enhanced MRI. In: Proceedings of an ISMRM Workshop: MR of Cancer: Physiology and Metabolism, Baltimore, MD, 1996. p 61.
4. Heywang-Koebrunner SH, Viehweg P. Sensitivity of contrast-enhanced MR imaging of the breast. Magn Reson Imaging Clin North Am 1994;2:527-38.
5. van Dijke CF, Brasch RC, Roberts TP, et al Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histological capillary density. Radiology 1996;198:813-818.
6. Su MY, Mühler A, Lao X, Nalcioglu O. Tumor characterization with dynamic contrast enhanced MRI using MR contrast agents of various molecular weights, Magn Reson Med 1998;39:259-269.
7. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyper-permeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
8. Claffey KP, Robinson GS. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metast Rev 1996;15:165-176.
9. Cohen FM, Kuwatsuru R, Shames DM. et al Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation. Invest Radiol 1994;29:970-977.
10. Schwickert HC, Stiskal M, Roberts TP, et al Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy. Radiology 1996;198:893-898.
11. Knopp MV, Brix G, Junkermann HJ, Sinn HP. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin North Am 1994;2:633-658.
12. Su MY, Jao JC, Nalcioglu O. Measurements of vascular volume fraction and blood-tissue permeability constants with pharmacokinetic model: studies in rat muscle tumor. Magn Reson Med 1994;32: 714-724.
13. Su MY, Najafi AA, Nalcioglu O. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med 1995;34:402-411.
14. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
15. Donahue KM, Weisskoff RM, Parmelee DJ, et al Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction. Magn Reson Med 1995;34:423-432.
16. Donahue KM, Weisskoff RM, Bursteln D. Water diffusion and exchange as they influence contrast enhancement, J Magn Reson Imaging 1997;7:102-110.
17. Tofts P, Kermode A. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-367.
18. Larsson H, Stubgaard M, Frederiksen J, Jensen M, Henriksen O, Paulson O. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-131.
19. Brix G, Semmler W, Port R, Schad L, Layer G, Lorenz W. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-628.
20. Shames D, Kuwatsuru R, Vexler V, Muhler A, Brasch RC. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn Reson Med 1993;29:616-622.
21. Jain RK. Transport of molecules across tumor vasculature. Cancer Metast Rev 1987;6:559-593.
22. Baxter LT, Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987;47:3039-3051.
23. Su MY, Lao X, Nalcioglu O. Quantitative comparison of pharmacokinetics of polylysine-Gd-DTPA, Gd-DTPA-24-cascade-polymer, and Gd-DTPA in blood, liver, and tumor of rats. In: Proceedings of the 4th SMR Annual Meeting, New York, 1996. p 1697.
24. Jain RK. Physiological resistance to the treatment of solid tumors. In: Teicher BA, editor. Drug resistance in oncology. New York: Marcel Dekker; 1993. p 87.
25. Reddick WE, Bhargava R, Taylor JS, Meyer WH, Fletcher BD. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy. J Magn Reson Imaging 1995;5:689-694.
26. Brasch RC, Pham C, Shames D, et al Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
27. Peters CE, Trotter MJ, Chaplin DJ. Early spatial and temporal changes in tumour perfusion after administration of flavone acetic acid. Int J Radiat Biol 1991;60:41-48.
28. Aicher KP, Dupon JW, White DL, et al Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha. Cancer Res 1990;50: 7376-7381.
29. Demsar F, Roberts TP, Schwickert HC, et al A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997;37:236-242.
30. Daldrup HE, Brasch RC, Muehler A, et al MRI quantification of tumor microvascular permeability using macromolecular contrast media: comparison between Gd24-cascade-polymer and albumin-Gd-DTPA. In: Proceedings of the 5th ISMRM Annual Meeting, Vancouver, B C, Canada, 1997. p 1592.